Search Results - "Boehringer, Johannes"

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS by Kappos, Ludwig, Radue, Ernst-Wilhelm, Comi, Giancarlo, Montalban, Xavier, Butzkueven, Helmut, Wiendl, Heinz, Giovannoni, Gavin, Hartung, Hans-Peter, Derfuss, Tobias, Naegelin, Yvonne, Sprenger, Till, Mueller-Lenke, Nicole, Griffiths, Sarah, von Rosenstiel, Philipp, Gottschalk, Rebecca, Zhang, Ying, Dahlke, Frank, Tomic, Davorka

“…OBJECTIVE:To investigate the effect of different natalizumab washout (WO) periods on recurrence of MRI and clinical disease activity in patients switching from…”
Get full text

Combination treatment of fingolimod with antidepressants in relapsing–remitting multiple sclerosis patients with depression: a multicentre, open-label study – REGAIN by Bayas, Antonios, Schuh, Katrin, Baier, Monika, Vormfelde, Stefan Viktor, Koppai-Reiner, Joachim, Strauss, Erik, Haerting, Beatrix, Wiehler, Stephan, Boehringer, Johannes, Laumen, Peter, Christopher, Angelika, Pfeiffer, Uwe, Hofmann, Werner, Horn, Rolf, Lauter, Thorsten, Polzer, Udo, Halbgewachs, Frank, Siever, Arno, Honig, Holger, Mahler, Andreas, Kuhlgert, Karsten, Weber, Martin, Bischof, Felix, Martin Hoffmann, Olaf, Merkelbach, Stefan, Ralf Kessler, Kirn, Wenzelburger, Roland, Mayer, Geert, Strittmatter, Matthias

“…Objectives: Approximately one in two patients with multiple sclerosis (MS) suffer from comorbid depression. The primary objective of this study was to evaluate…”
Get full text